Question 1

What is the typical CAPEX range for setting up a Romidepsin manufacturing plant?

Accepted Answer

USD 25 million to USD 60 million for a 50 to 300 kg per year unit.

Question 2

What is the typical plant capacity or benchmark scale for a Romidepsin manufacturing facility?

Accepted Answer

The typical capacity is 50 to 300 kg per year.

Question 3

What is the current market size and growth rate for Romidepsin?

Accepted Answer

The global romidepsin market is estimated at USD 40 million to USD 90 million, with a CAGR of about 3.8% to 4.5%.

Question 4

What are the main end-use segments for Romidepsin, and what share of demand does each represent?

Accepted Answer

Cutaneous T-cell lymphoma accounts for 55% to 70% of demand, oncology research and clinical studies for 15% to 25%, other lymphoma and hospital use for 8% to 12%, and reference and analytical applications for 5% to 10%.

Question 5

What is the reaction or synthesis route and key intermediates used to manufacture Romidepsin?

Accepted Answer

Romidepsin is produced through submerged fermentation of Chromobacterium violaceum, followed by extraction, adsorption, chromatography, and crystallization.

Question 6

What are the key intermediate or API cost requirements, and what share of raw material cost do they represent?

Accepted Answer

Fermentation media and chromatography resins are the main consumables and account for about 50% to 65% of total consumable costs.

Question 7

What share of total capital cost do the core reaction and purification equipment represent?

Accepted Answer

Fermenters and chromatography and purification equipment account for about 45% to 55% of total plant setup costs.

Question 8

What factors drive Romidepsin manufacturing cost the most?

Accepted Answer

Low fermentation yield and purification consumables are the main cost drivers, together accounting for about 55% to 70% of variable operating costs.

Question 9

In which regions is Romidepsin manufacturing capacity concentrated?

Accepted Answer

Manufacturing capacity is concentrated in the United States, Japan, India, and China.

Question 10

What grades or specifications are available for Romidepsin?

Accepted Answer

Romidepsin is supplied as a pharmaceutical-grade API and as a sterile lyophilized powder for injection. The approved product is supplied in a 10 mg single-dose vial.

Question 11

What regulatory requirements (FDA, EMA, GMP, DMF filings) apply to Romidepsin manufacturing?

Accepted Answer

Manufacturing requires GMP compliance, appropriate permits for fermentation and cytotoxic API handling, validated processes, and quality-control testing.

Romidepsin Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

About the Author

Vishakha Agrawal

Frequently Asked Questions